Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
3.890
-0.140 (-3.47%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $104.87 million as of October 31, 2024.
Market Cap
104.87M
Enterprise Value
-74.42M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on February 2, 2024, Alto Neuroscience's market cap has decreased from $409.04M to $104.87M, a decrease of -74.36%. That is a compound annual growth rate of -84.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 108.60M | -73.45% |
| Feb 2, 2024 | 409.04M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 106.48M |
| AlloVir | 106.13M |
| Adicet Bio | 105.47M |
| Relmada Therapeutics | 105.01M |
| Sensus Healthcare | 104.89M |
| OptiNose | 104.04M |
| Pro-Dex | 103.07M |
| Harvard Bioscience | 102.49M |